Aligos Therapeutics, Inc. (NASDAQ: ALGS), a clinical-stage biotechnology Company announced the discontinuation of dosing in the first cohort of its candidate ALG-020572, intended for the treatment of chronic hepatitis B. The dosing was stopped after a patient experienced a serious adverse event (SAE) and a...
On March 14 2022, The Nektar Therapeutics (NASDAQ: NKTR) announced that a review by an independent Data Monitoring Committee (DMC) evaluating the safety and efficacy of bempegaldesleukin in combination with Opdivo (nivolumab), revealed that the study has failed to meet the primary endpoints of progression-free...
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) is a clinical-stage biotechnology Company is focussed on creating novel therapeutics for the treatment of neurodegenerative diseases such as ALS and Alzheimer’s. The Company is awaiting the decision on its NDA for AMX0035 (sodium phenylbutyrate (PB) and taurursodiol (TURSO; also...
Axcelis Technologies, Inc. (NASDAQ: ACLS) is leveraging its leading-edge Purion Platform to create a comprehensive suite of ion implanters that combine precision, quality, purity and low cost of ownership. Axcelis’ source technology uses H2 as a co-gas with fluorine-based dopants leading to minimal glitches, optimizing...
AST SpaceMobile, Inc. (NASDAQ: ASTS) announced the signing of a multi-launch agreement with Space Exploration Technologies Corp. The agreement covers the launch of the BlueWalker 3 test satellite (BW3), intended to be launched this summer, along with the launch of the first BlueBird satellite, besides...
Beyond Meat, Inc. (NASDAQ: BYND) aims to drive a shift from animal to plant-based meat in order to promote healthier choices, combat climate change and conserve natural resources. The Company is using leading-edge innovation with high-quality non-GMO ingredients to deliver high protein meat substitutes that...
8th March celebrates the cultural, political and socioeconomic achievements of women from different strata and geographies across the globe. Femtech, a category that leverages technology to address issues related to women’s health, is poised to become a $50 billion dollar industry by year 2025, according...
Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced that it is pausing enrolment for an ongoing late-stage study evaluating its lead COVID-19 vaccine candidate INO-4800, as lab tests show that the candidate had significantly lower levels of antibodies against the Omicron variant. The Company is now planning changes...
Shelving of Gene Therapy Spin Off Amicus Therapeutics, Inc. (NASDAQ: FOLD), a biotechnology company developing cutting-edge therapeutics for treatment of rare metabolic diseases, announced that the proposed Business Combination Agreement with ARYA Sciences Acquisition Corp IV, a special purpose acquisition company has been mutually terminated owing...
LivePerson, Inc. (NASDAQ: LPSN) offers conversational artificial intelligence solutions for enterprise and consumer segments in the United States, Canada, Latin America, South America, Europe, the Middle East, Africa, and the Asia-Pacific region. The Company’s Curiously Human AI combines Natural Language Understanding (NLU), Natural Language Processing...
